ReviewFrontiers in medicine2015
State-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PET.
Review in Frontiers in medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- [Asia Oceania journal of nuclear medicine & biology · 2025Article
- Article
- Impact of time of flight and point spread function on quantitative parameters of lung lesions inBMC medical imaging · 2021Article
- FDG-PET/CT in Lymphoma: Where Do We Go Now?Cancers · 2021Article
- Letter to the Editor: It is time for the nuclear medicine community to define a unit for the total lesion glycolysis (TLG) and similar metrics.European journal of nuclear medicine and molecular imaging · 2021Article
- Review
- Metabolic tumor volume predicts overall survival in patients with primary pulmonary lymphoepithelioma-like carcinoma.Oncology letters · 2019Article
- Review
- Does simplified quantitative analysis ofJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2019Article
- Article
- Perspectives on Small Animal Radionuclide Imaging; Considerations and Advances in Atherosclerosis.Frontiers in medicine · 2019Review
- Prognostic value of metabolic tumor volume of pretreatmentBMC medical imaging · 2018Article
- Towards enhanced PET quantification in clinical oncology.The British journal of radiology · 2018Review
- Radiogenomic Analysis of Oncological Data: A Technical Survey.International journal of molecular sciences · 2017Review
- Correlation of Molecular Subtypes of Invasive Ductal Carcinoma of Breast with Glucose Metabolism in FDG PET/CT: Based on the Recommendations of the St. Gallen Consensus Meeting 2013.Nuclear medicine and molecular imaging · 2017Article
- Quantification of Lung PET Images: Challenges and Opportunities.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2017Review
- Characterization of PET/CT images using texture analysis: the past, the present… any future?European journal of nuclear medicine and molecular imaging · 2017Review
- Article
- Practical no-gold-standard evaluation framework for quantitative imaging methods: application to lesion segmentation in positron emission tomography.Journal of medical imaging (Bellingham, Wash.) · 2017Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
(18)F-fluoro-2-deoxyglucose ((18)F-FDG) positron emission tomography (PET) is an important tool in oncology. Its use has greatly progressed from initial diagnosis to staging and patient monitoring. The information derived from (18)F-FDG-PET allowed the development of a wide range of PET quantitative analysis techniques ranging from simple semi-quantitative methods like the standardized uptake value (SUV) to "high order metrics" that require a segmentation step and additional image processing. In this review, these methods are discussed, focusing particularly on the available methodologies that can be used in clinical trials as well as their current applications in international consensus for PET interpretation in lymphoma and solid tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.